Millennium Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Millennium Management's PTCT Position: Q3 2026 in Review
Millennium Management reduced its PTC Therapeutics (PTCT) stake by 19% in Q3 2026, selling an estimated $649K and leaving 37,580 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3743.
Millennium Management first reported a position in PTCT in Q2 2014 and has held it in 41 quarters since. The position peaked at $64.8M in Q3 2025. 361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Millennium Management held 37,580 shares of PTC Therapeutics worth $2.43M as of Q3 2026.
- Millennium Management sold 8,914 PTC Therapeutics shares in Q3 2026, an estimated $649K.
- PTC Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3743 holding.
- Millennium Management first reported a position in PTC Therapeutics in Q2 2014 and has held it in 41 quarters since.
- Millennium Management's PTC Therapeutics position peaked at $64.8M in Q3 2025.
- 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.